Want to join the conversation?
$UHS 2Q15 Call: Increasing estimated range of adjusted net income attributable to UHS for 2015 to $6.75-7.15 per diluted share. This revised guidance, which excludes the expected electronic health records impact for the year represents an increase of approx. 9-10% from the previously provided range of $6.15-6.55 per diluted share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?